Cargando…

Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy

BACKGROUND: We sought to determine which parsimonious combination of complete blood count (CBC)-based biomarkers most efficiently predicts oncologic outcomes in patients undergoing radical cystectomy (RC) for bladder cancer (BC). METHODS: Using our institutional RC database (1992–2012), nine CBC-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhindi, Bimal, Hermanns, Thomas, Wei, Yanliang, Yu, Julie, Richard, Patrick O, Wettstein, Marian S, Templeton, Arnoud, Li, Kathy, Sridhar, Srikala S, Jewett, Michael A S, Fleshner, Neil E, Zlotta, Alexandre R, Kulkarni, Girish S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815810/
https://www.ncbi.nlm.nih.gov/pubmed/26657651
http://dx.doi.org/10.1038/bjc.2015.432
_version_ 1782424634288766976
author Bhindi, Bimal
Hermanns, Thomas
Wei, Yanliang
Yu, Julie
Richard, Patrick O
Wettstein, Marian S
Templeton, Arnoud
Li, Kathy
Sridhar, Srikala S
Jewett, Michael A S
Fleshner, Neil E
Zlotta, Alexandre R
Kulkarni, Girish S
author_facet Bhindi, Bimal
Hermanns, Thomas
Wei, Yanliang
Yu, Julie
Richard, Patrick O
Wettstein, Marian S
Templeton, Arnoud
Li, Kathy
Sridhar, Srikala S
Jewett, Michael A S
Fleshner, Neil E
Zlotta, Alexandre R
Kulkarni, Girish S
author_sort Bhindi, Bimal
collection PubMed
description BACKGROUND: We sought to determine which parsimonious combination of complete blood count (CBC)-based biomarkers most efficiently predicts oncologic outcomes in patients undergoing radical cystectomy (RC) for bladder cancer (BC). METHODS: Using our institutional RC database (1992–2012), nine CBC-based markers (including both absolute cell counts and ratios) were evaluated based on pre-treatment measurements. The outcome measures were recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS). Time-dependent receiver-operating characteristics curves were used to characterise each biomarker. The CBC-based biomarkers, along with several clinical predictors, were then considered for inclusion in predictive multivariable Cox models based on the Akaike Information Criterion. RESULTS: Our cohort included 418 patients. Neutrophil–lymphocyte ratio (NLR) was the only biomarker satisfying criteria for inclusion into all models, independently predicting RFS (HR per 1-log unit=1.52, 95% CI=1.17–1.98, P=0.002), CSS (HR=1.47, 95% CI=1.20–1.80, P<0.001), and OS (HR=1.56, 95% CI=1.16–2.10, P=0.004). Haemoglobin was also independently predictive of CSS (HR per 1 g/dl=0.91, 95% CI=0.86–0.95, P<0.001) and OS (HR=0.90, 95% CI=0.88–0.93, P<0.001), but not RFS. CONCLUSIONS: Among CBC biomarkers studied, NLR was the most efficient marker for predicting RFS, whereas NLR and haemoglobin were most efficient in predicting CSS and OS. NLR and haemoglobin are promising, cost-effective, independent biomarkers for predicting oncologic BC outcomes following RC. CONDENSED ABSTRACT: Various CBC-based biomarkers have separately been shown to be predictive of oncologic outcomes in patients undergoing cystectomy for BC. Our study evaluated these biomarkers, and determined that NLR is the best CBC-based biomarker for predicting RFS, whereas NLR and haemoglobin are most efficient for predicting CSS and OS.
format Online
Article
Text
id pubmed-4815810
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48158102017-01-19 Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy Bhindi, Bimal Hermanns, Thomas Wei, Yanliang Yu, Julie Richard, Patrick O Wettstein, Marian S Templeton, Arnoud Li, Kathy Sridhar, Srikala S Jewett, Michael A S Fleshner, Neil E Zlotta, Alexandre R Kulkarni, Girish S Br J Cancer Molecular Diagnostics BACKGROUND: We sought to determine which parsimonious combination of complete blood count (CBC)-based biomarkers most efficiently predicts oncologic outcomes in patients undergoing radical cystectomy (RC) for bladder cancer (BC). METHODS: Using our institutional RC database (1992–2012), nine CBC-based markers (including both absolute cell counts and ratios) were evaluated based on pre-treatment measurements. The outcome measures were recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS). Time-dependent receiver-operating characteristics curves were used to characterise each biomarker. The CBC-based biomarkers, along with several clinical predictors, were then considered for inclusion in predictive multivariable Cox models based on the Akaike Information Criterion. RESULTS: Our cohort included 418 patients. Neutrophil–lymphocyte ratio (NLR) was the only biomarker satisfying criteria for inclusion into all models, independently predicting RFS (HR per 1-log unit=1.52, 95% CI=1.17–1.98, P=0.002), CSS (HR=1.47, 95% CI=1.20–1.80, P<0.001), and OS (HR=1.56, 95% CI=1.16–2.10, P=0.004). Haemoglobin was also independently predictive of CSS (HR per 1 g/dl=0.91, 95% CI=0.86–0.95, P<0.001) and OS (HR=0.90, 95% CI=0.88–0.93, P<0.001), but not RFS. CONCLUSIONS: Among CBC biomarkers studied, NLR was the most efficient marker for predicting RFS, whereas NLR and haemoglobin were most efficient in predicting CSS and OS. NLR and haemoglobin are promising, cost-effective, independent biomarkers for predicting oncologic BC outcomes following RC. CONDENSED ABSTRACT: Various CBC-based biomarkers have separately been shown to be predictive of oncologic outcomes in patients undergoing cystectomy for BC. Our study evaluated these biomarkers, and determined that NLR is the best CBC-based biomarker for predicting RFS, whereas NLR and haemoglobin are most efficient for predicting CSS and OS. Nature Publishing Group 2016-01-19 2015-12-10 /pmc/articles/PMC4815810/ /pubmed/26657651 http://dx.doi.org/10.1038/bjc.2015.432 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Molecular Diagnostics
Bhindi, Bimal
Hermanns, Thomas
Wei, Yanliang
Yu, Julie
Richard, Patrick O
Wettstein, Marian S
Templeton, Arnoud
Li, Kathy
Sridhar, Srikala S
Jewett, Michael A S
Fleshner, Neil E
Zlotta, Alexandre R
Kulkarni, Girish S
Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy
title Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy
title_full Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy
title_fullStr Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy
title_full_unstemmed Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy
title_short Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy
title_sort identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy
topic Molecular Diagnostics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815810/
https://www.ncbi.nlm.nih.gov/pubmed/26657651
http://dx.doi.org/10.1038/bjc.2015.432
work_keys_str_mv AT bhindibimal identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT hermannsthomas identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT weiyanliang identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT yujulie identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT richardpatricko identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT wettsteinmarians identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT templetonarnoud identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT likathy identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT sridharsrikalas identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT jewettmichaelas identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT fleshnerneile identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT zlottaalexandrer identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy
AT kulkarnigirishs identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy